Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2007

Open Access 01-12-2007 | Research

Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study

Authors: Medea Imboden, Sara H Downs, Oliver Senn, Gabor Matyas, Otto Brändli, Erich W Russi, Christian Schindler, Ursula Ackermann-Liebrich, Wolfgang Berger, Nicole M Probst-Hensch, the SAPALDIA Team

Published in: Respiratory Research | Issue 1/2007

Login to get access

Abstract

Background

Understanding the environmental and genetic risk factors of accelerated lung function decline in the general population is a first step in a prevention strategy against the worldwide increasing respiratory pathology of chronic obstructive pulmonary disease (COPD). Deficiency in antioxidative and detoxifying Glutathione S-transferase (GST) gene has been associated with poorer lung function in children, smokers and patients with respiratory diseases. In the present study, we assessed whether low activity variants in GST genes are also associated with accelerated lung function decline in the general adult population.

Methods

We examined with multiple regression analysis the association of polymorphisms in GSTM1, GSTT1 and GSTP1 genes with annual decline in FEV1, FVC, and FEF25–75 during 11 years of follow-up in 4686 subjects of the prospective SAPALDIA cohort representative of the Swiss general population. Effect modification by smoking, gender, bronchial hyperresponisveness and age was studied.

Results

The associations of GST genotypes with FEV1, FVC, and FEF25–75 were comparable in direction, but most consistent for FEV1. GSTT1 homozygous gene deletion alone or in combination with GSTM1 homozygous gene deletion was associated with excess decline in FEV1 in men, but not women, irrespective of smoking status. The additional mean annual decline in FEV1 in men with GSTT1 and concurrent GSTM1 gene deletion was -8.3 ml/yr (95% confidence interval: -12.6 to -3.9) relative to men without these gene deletions. The GSTT1 effect on the FEV1 decline comparable to the observed difference in FEV1 decline between never and persistent smoking men. Effect modification by gender was statistically significant.

Conclusion

Our results suggest that genetic GSTT1 deficiency is a prevalent and strong determinant of accelerated lung function decline in the male general population.
Literature
1.
2.
3.
Kunzli N, Ackermann-Liebrich U, Brandli O, Tschopp JM, Schindler C, Leuenberger P: Clinically "small" effects of air pollution on FVC have a large public health impact. Swiss Study on Air Pollution and Lung Disease in Adults (SAPALDIA) - team. Eur Respir J 2000, 15:131–136.CrossRefPubMed
4.
Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, Johns DP, Walters EH, Abramson MJ: Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 2005, 60:645–651.CrossRefPubMedPubMedCentral
5.
Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, Kramer U: Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 2005, 6:152.CrossRefPubMedPubMedCentral
6.
Eisner MD, Balmes J, Yelin EH, Katz PP, Hammond SK, Benowitz N, Blanc PD: Directly measured secondhand smoke exposure and COPD health outcomes. BMC Pulm Med 2006, 6:12.CrossRefPubMedPubMedCentral
7.
DeMeo DL, Silverman EK: Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 2004, 59:259–264.CrossRefPubMedPubMedCentral
8.
Demeo DL, Mariani TJ, Lange C, Srisuma S, Litonjua AA, Celedon JC, Lake SL, Reilly JJ, Chapman HA, Mecham BH, Haley KJ, Sylvia JS, Sparrow D, Spira AE, Beane J, Pinto-Plata V, Speizer FE, Shapiro SD, Weiss ST, Silverman EK: The SERPINE2 Gene Is Associated with Chronic Obstructive Pulmonary Disease. Am J Hum Genet 2006, 78:253–264.CrossRefPubMed
9.
Kelleher CM, Silverman EK, Broekelmann T, Litonjua AA, Hernandez M, Sylvia JS, Stoler J, Reilly JJ, Chapman HA, Speizer FE, Weiss ST, Mecham RP, Raby BA: A functional mutation in the terminal exon of elastin in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2005, 33:355–362.CrossRefPubMedPubMedCentral
10.
Guenegou A, Leynaert B, Benessiano J, Pin I, Demoly P, Neukirch F, Boczkowski J, Aubier M: Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet 2006, 43:e43.CrossRefPubMedPubMedCentral
11.
Hersh CP, Demeo DL, Lazarus R, Celedon JC, Raby BA, Benditt JO, Criner G, Make B, Martinez FJ, Scanlon PD, Sciurba FC, Utz JP, Reilly JJ, Silverman EK: Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:977–984.CrossRefPubMedPubMedCentral
12.
Hoffjan S, Stemmler S, Parwez Q, Petrasch-Parwez E, Arinir U, Rohde G, Reinitz-Rademacher K, Schultze-Werninghaus G, Bufe A, Epplen JT: Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease. BMC Med Genet 2005, 6:34.CrossRefPubMedPubMedCentral
13.
Cheng SL, Yu CJ, Chen CJ, Yang PC: Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004, 23:818–824.CrossRefPubMed
14.
Hayes JD, Pulford DJ: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995, 30:445–600.CrossRefPubMed
15.
Hayes JD, Strange RC: Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61:154–166.CrossRefPubMed
16.
Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macias H, Reyes-Ruiz NI, Estela del Rio-Navarro B, Hernandez-Avila M, London SJ: Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 2004, 59:8–10.PubMedPubMedCentral
17.
Aynacioglu AS, Nacak M, Filiz A, Ekinci E, Roots I: Protective role of glutathione S-transferase P1 (GSTP1) Val105Val genotype in patients with bronchial asthma. Br J Clin Pharmacol 2004, 57:213–217.CrossRefPubMedPubMedCentral
18.
Flamant C, Henrion-Caude A, Boelle PY, Bremont F, Brouard J, Delaisi B, Duhamel JF, Marguet C, Roussey M, Miesch MC, Boule M, Strange RC, Clement A: Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosis. Pharmacogenetics 2004, 14:295–301.CrossRefPubMed
19.
He JQ, Ruan J, Connett JE, Anthonisen NR, Pare PD, Sandford AJ: Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002, 166:323–328.CrossRefPubMed
20.
Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L: Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 2002, 166:710–716.CrossRefPubMed
21.
Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, Schindler C, Felber Dietrich D, Zemp Stutz E, Bayer-Oglesby L, Baum F, Brändli O, Brutsche M, Downs SH, Keidel D, Gerbase MW, Imboden M, Keller R, Knöpfli B, Künzli N, Nicod L, Pons M, Staedele P, Tschopp JM, Zellweger JP, Leuenberger P, team SAPALDIA: Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991–2003: methods and characterization of participants. Soz Praventiv Med 2005, 50:245–263.CrossRef
22.
Martin BW, Ackermann-Liebrich U, Leuenberger P, Kunzli N, Stutz EZ, Keller R, Zellweger JP, Wuthrich B, Monn C, Blaser K, Bolognini G, Bongard JP, Brandli O, Braun P, Defila C, Domenighetti G, Grize L, Karrer W, Keller-Wossidlo H, Medici TC, Peeters A, Perruchoud AP, Schindler C, Schoeni MH, Villiger B, et al.: SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed 1997, 42:67–84.CrossRefPubMed
23.
Kunzli N, Kuna-Dibbert B, Keidel D, Keller R, Brändli O, Schindler C, Schweinzer KM, Leuenberger P, Ackermann-Liebrich U, team SAPALDIA: Longitudinal validity of spirometers - a challenge in lung function follow-up studies. Swiss Medical Weekly 2005, 135(33–34):503–508.
24.
Standardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med 1995, 152:1107–1136.
25.
Schneider S, Roessli D, Excoffier L: Arlequin ver 2000: A software for population genetics data analysis. Genetics & Biometry Laboratory, University of Geneva, Switzerland 2000.
26.
27.
Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR: The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 2000, 9:1329–1334.PubMed
28.
Fryer AA, Bianco A, Hepple M, Jones PW, Strange RC, Spiteri MA: Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med 2000, 161:1437–1442.CrossRefPubMed
29.
Brutsche MH, Downs SH, Schindler C, Gerbase MW, Schwartz J, Frey M, Russi EW, Ackermann-Liebrich U, Leuenberger P: Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 2006, 61:671–677.CrossRefPubMedPubMedCentral
30.
Janssens JP, Pache JC, Nicod LP: Physiological changes in respiratory function associated with ageing. Eur Respir J 1999, 13:197–205.CrossRefPubMed
31.
Kabesch M, Hoefler C, Carr D, Leupold W, Weiland SK, von Mutius E: Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax 2004, 59:569–573.CrossRefPubMedPubMedCentral
32.
Morabia A, Sorenson A, Kumanyika SK, Abbey H, Cohen BH, Chee E: Vitamin A, cigarette smoking, and airway obstruction. Am Rev Respir Dis 1989, 140:1312–1316.CrossRefPubMed
33.
Britton JR, Pavord ID, Richards KA, Knox AJ, Wisniewski AF, Lewis SA, Tattersfield AE, Weiss ST: Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995, 151:1383–1387.CrossRefPubMed
34.
Tujague J, Bastaki M, Holland N, Balmes JR, Tager IB: Antioxidant intake, GSTM1 polymorphism and pulmonary function in healthy young adults. Eur Respir J 2006, 27:282–288.CrossRefPubMed
35.
Kelly FJ, Dunster C, Mudway I: Air pollution and the elderly: oxidant/antioxidant issues worth consideration. Eur Respir J Suppl 2003, 40:70s-75s.CrossRefPubMed
36.
Wise RA: The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Am J Med 2006, 119:4–11.CrossRefPubMed
37.
Niewoehner DE, Kleinerman J, Rice DB: Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974, 291:755–758.CrossRefPubMed
38.
Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Tellez-Rojo MM, Moreno-Macias H, Reyes-Ruiz NI, del Rio-Navarro BE, Ruiz-Navarro MX, Hatch G, Slade R, Hernandez-Avila M: Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. Am J Respir Crit Care Med 2002, 166:703–709.CrossRefPubMed
39.
Hong YC, Leem JH, Lee KH, Park DH, Jang JY, Kim ST, Ha EH: Exposure to air pollution and pulmonary function in university students. Int Arch Occup Environ Health 2005, 78:132–138.CrossRefPubMed
40.
DeMeo DL, Celedon JC, Lange C, Reilly JJ, Chapman HA, Sylvia JS, Speizer FE, Weiss ST, Silverman EK: Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:1294–1301.CrossRefPubMed
41.
42.
Griffith KA, Sherrill DL, Siegel EM, Manolio TA, Bonekat HW, Enright PL: Predictors of loss of lung function in the elderly: the Cardiovascular Health Study. Am J Respir Crit Care Med 2001, 163:61–68.CrossRefPubMed
43.
Downs SH, Brandli O, Zellweger JP, Schindler C, Kunzli N, Gerbase MW, Burdet L, Bettschart R, Zemp Stutz E, Frey M, Keller R, Tschopp JM, Leuenberger P, Ackermann-Liebrich U, team SAPALDIA: Heterogeneity in effects from smoking on lung function decline between men and women - SAPALDIA 2 cohort study. Respir Res 2005, 6:45.CrossRefPubMedPubMedCentral
44.
Connett JE, Murray RP, Buist AS, Wise RA, Bailey WC, Lindgren PG, Owens GR: Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 2003, 157:973–979.CrossRefPubMed
45.
Chen Y, Horne SL, Dosman JA: Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis 1991, 143:1224–1230.CrossRefPubMed
46.
Ryberg D, Hewer A, Phillips DH, Haugen A: Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994, 54:5801–5803.PubMed
47.
Lam S, leRiche JC, Zheng Y, Coldman A, MacAulay C, Hawk E, Kelloff G, Gazdar AF: Sex-related differences in bronchial epithelial changes associated with tobacco smoking. J Natl Cancer Inst 1999, 91:691–696.CrossRefPubMed
48.
Ilhan N, Kamanli A, Ozmerdivenli R: Variable effects of exercise intensity on reduced glutathione, thiobarbituric acid reactive substance levels, and glucose concentration. Arch Med Res 2004, 35:294–300.CrossRefPubMed
49.
Rush JW, Sandiford SD: Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity. Clin Biochem 2003, 36:345–351.CrossRefPubMed
50.
Fano G, Mecocci P, Vecchiet J, Belia S, Fulle S, Polidori MC, Felzani G, Senin U, Vecchiet L, Beal MF: Age and sex influence on oxidative damage and functional status in human skeletal muscle. J Muscle Res Cell Motil 2001, 22:345–351.CrossRefPubMed
51.
Mendoza-Nunez VM, Sanchez-Rodriguez MA, Retana-Ugalde R, Vargas-Guadarrama LA, Altamirano-Lozano MA: Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly. Mech Ageing Dev 2001, 122:835–847.CrossRefPubMed
52.
Montano MM, Deng H, Liu M, Sun X, Singal R: Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 2004, 23:2442–2453.CrossRefPubMed
53.
He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ: Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 2004, 170:388–394.CrossRefPubMed
54.
Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, Ouchi Y: Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999, 54:693–696.CrossRefPubMedPubMedCentral
55.
Brandli O, Schindler C, Kunzli N, Keller R, Perruchoud AP: Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. Thorax 1996, 51:277–283.CrossRefPubMedPubMedCentral
56.
Brandli O, Schindler C, Leuenberger PH, Baur X, Degens P, Kunzli N, Keller R, Perruchoud AP: Re-estimated equations for 5th percentiles of lung function variables. Thorax 2000, 55:173–174.CrossRefPubMed
57.
Kohlhaufl M, Brand P, Scheuch G, Meyer TS, Schulz H, Haussinger K, Heyder J: Increased fine particle deposition in women with asymptomatic nonspecific airway hyperresponsiveness. Am J Respir Crit Care Med 1999, 159:902–906.CrossRefPubMed
58.
Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG: Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000, 55:121–125.CrossRefPubMedPubMedCentral
59.
Strange RC, Spiteri MA, Ramachandran S, Fryer AA: Glutathione-S-transferase family of enzymes. Mutat Res 2001, 482:21–26.CrossRefPubMed
60.
Piipari R, Nurminen T, Savela K, Hirvonen A, Mantyla T, Anttila S: Glutathione S-transferases and aromatic DNA adducts in smokers' bronchoalveolar macrophages. Lung Cancer 2003, 39:265–272.CrossRefPubMed
61.
Elsby R, Kitteringham NR, Goldring CE, Lovatt CA, Chamberlain M, Henderson CJ, Wolf CR, Park BK: Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem 2003, 278:22243–22249.CrossRefPubMed
62.
Ishii T, Fujishiro M, Masuda M, Nakajima J, Teramoto S, Ouchi Y, Matsuse T: Depletion of glutathione S-transferase P1 induces apoptosis in human lung fibroblasts. Exp Lung Res 2003, 29:523–536.CrossRefPubMed
63.
Deng HW, Chen WM, Recker RR: Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics 2001, 157:885–897.PubMedPubMedCentral
64.
Pritchard JK, Rosenberg NA: Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999, 65:220–228.CrossRefPubMedPubMedCentral
65.
Roewer L, Croucher PJ, Willuweit S, Lu TT, Kayser M, Lessig R, de Knijff P, Jobling MA, Tyler-Smith C, Krawczak M: Signature of recent historical events in the European Y-chromosomal STR haplotype distribution. Hum Genet 2005, 116:279–291.CrossRefPubMed
Metadata
Title
Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study
Authors
Medea Imboden
Sara H Downs
Oliver Senn
Gabor Matyas
Otto Brändli
Erich W Russi
Christian Schindler
Ursula Ackermann-Liebrich
Wolfgang Berger
Nicole M Probst-Hensch
the SAPALDIA Team
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2007
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-8-2

Other articles of this Issue 1/2007

Respiratory Research 1/2007 Go to the issue

Research

Endothelin-1 in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction

Research

Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial

Research

Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease

Research

Differences in susceptibility to German cockroach frass and its associated proteases in induced allergic inflammation in mice

Research

Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an α-smooth muscle actin-Cre transgenic mouse

Research

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits